Whan In Pharm Co.,Ltd. (016580.KS)

KRW 11930.0

(-0.33%)

Market Cap (In KRW)

182.13 Billion

Revenue (In KRW)

230.39 Billion

Net Income (In KRW)

29.77 Billion

Avg. Volume

27.46 Thousand

Currency
KRW
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
11250.0-15900.0
PE
-
EPS
-
Beta Value
0.155
ISIN
KR7016580003
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Wonbum Lee
Employee Count
-
Website
https://www.whanin.com
Ipo Date
2000-01-04
Details
Whan In Pharm Co.,Ltd., a pharmaceutical company, develops, manufactures, markets, and sells therapeutic products in South Korea. It offers anti-depressants, anti-psychotics, nootropics and anti-dementia, anti-epileptics, cardiovascular, gastrointestinal, antibiotics, antiviral agents, antihistamines, anti-inflammatory and analgesics, metabolic disorders, respiratory, central nervous system, other drug products. The company was founded in 1978 and is headquartered in Seoul, South Korea.